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Abstract
The objective of the study was to assess cerebral mass, based on head circumfer-
ence measurements in neonates exposed to tobacco smoke in utero, and to deter-
mine the relative proportions of the cerebral and body mass. The study included
147 neonates born in the period 2003–2004 at the Princess Anna Mazowiecka Uni-
versityHospitalandadmittedtotheNeonatalandIntensiveCareDepartmentofthe
Medical University in Warsaw. Subjects were divided into three groups on the basis
ofmaternalstatusasactive,passive,ornonsmokersdeterminedbymaternalurinary
cotinine concentration and a questionnaire. Neonates whose mothers were active
smokersthroughoutthewholeperiodofpregnancyhadalowerheadcircumference
and in consequence a lower cerebral mass signiﬁcantly more frequently when com-
pared with those whose mothers were nonsmokers, P = 0.002. (Median difference
in cerebral mass was 48.27 g.) The risk of lower cerebral mass was 3.9 (1.4–10.8,
CI 95%) in the group of neonates whose mothers actively smoked cigarettes during
pregnancy. A negative correlation was seen between cerebral mass and maternal
urinary cotinine concentration (correlation coefﬁcient r =− 23, P = 0.006). The
ratio of the cerebral to body mass was similar for neonates in all three groups.
Active smoking during pregnancy had a negative effect on the cerebral mass of the
neonate, however no such effect was observed in neonates whose mothers were
passive smokers. The deﬁciency in cerebral mass increased with greater smoking
intensity. Active smoking by the mother during pregnancy inhibits the growth of
the brain as well as that of the body mass of the neonate.
Introduction
Smoking during pregnancy causes neurological disorders in
the neonate, which are manifested by increased muscle ten-
sion, increased excitability, limb tremor, sleep disturbance
(nicotine withdrawal), and changes in the neurological de-
velopment of children (Law et al. 2003; Godding et al. 2004;
Pichini and Garcia-Algar 2006). General impairment of in-
tellectual ability of the child, a lower IQ, behavioral distur-
bance, and attention deﬁcit hyperactivity disorder (ADHD)
are also associated with the harmful effects of tobacco (Tha-
paretal.2003;Battyetal.2006;Linnetetal.2006;Martinetal.
2006).
Maternal tobacco smoking is one of the main risk factors
for sudden infant death syndrome (SIDS). This syndrome
occurs four times more frequently among neonates exposed
to tobacco smoke in utero and postpartum and twice as fre-
quently in neonates whose mothers did not smoke in preg-
nancy but did so postpartum (Schoendorf and Kiely 1992).
It is estimated that 80% of deaths due to SIDS are associated
withmaternalcigarettesmoking(Andersonetal.2005).Ithas
been demonstrated that SIDS in children exposed to tobacco
smokemaybecausedbyadisorderinthedevelopmentofthe
brain, namely the anatomical and functional changes in the
brain stem and the associated tendency for the occurrence of
central apnea (Matturri et al. 2006).
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Materials and Methods
The study included 147 neonates born during the period
2003–2004atthePrincessAnnaMazowieckaUniversityHos-
pital in Warsaw and admitted to the Neonatal and Intensive
Care Unit of the Medical University in Warsaw.
Inclusion in the study was conditional upon voluntary
consent by the mother and the completion of a question-
naire in which mothers assessed their degree of exposure to
tobacco smoke during pregnancy. Live neonates from sin-
gleton births were included in the study. The study protocol
was approved by the ethical committee of the Medical Uni-
versity in Warsaw—no. 34/2003 on 18 February 2003. The
study was conducted in accordance with the 1975 Helsinki
declaration. Neonates were divided into three groups based
upon the response to the questionnaire on exposure to to-
bacco smoke and on the concentration of maternal urinary
cotinine (nicotine metabolite).
T h e r ew e r e5 8s u b j e c t sb o r nt om o t h e r sw h od e c l a r e d
that they were active smokers with maternal urinary coti-
nine concentration of >200 ng/mg of creatinine. Neonates
whose mothers declared passive exposure to tobacco smoke
during pregnancy numbered 64 (maternal urinary cotinine
concentration 5–200 ng/mg of creatinine). The third group
included 25 subjects whose mothers declared no exposure to
tobaccosmokeduringpregnancyandwhoseurinarycotinine
concentrationwas<5ng/mgofcreatinine.Incaseofdiscrep-
ancy between declared lower exposure to tobacco smoke and
maternal urinary cotinine concentration, assignment to the
appropriategroupwasbaseduponthelatter.Twelveneonates
whose mothers had declared either passive exposure (5) or
no exposure (7) to tobacco smoke and for whom maternal
urinary cotinine concentration was >200 ng/mg of creati-
nine were assigned to the active smoker group. However, 19
womenwhohaddeclarednoexposuretotobaccosmokewere
identiﬁedaspassivesmokersonthebasisofaurinarycotinine
concentration of 5–200 ng/mg of creatinine. On the ﬁrst day
postpartum,5mLofurinewastakenfromthemothers.Urine
samples were frozen at a temperature of −80◦Ca n ds t o r e d
until urinary cotinine measurement was performed. Urinary
cotinine concentration was measured by high-performance
liquid chromatography with spectrophotometric detection
and norephedrine was used as an internal marker, following
earlierliquid–liquidextraction.Theconcentrationofurinary
cotininewasmeasuredinng/mLandthenexpressedasmgof
creatinine (ng/mg of creatinine), in order to avoid errors as-
sociatedwithexcessivedilutionorconcentrationoftheurine.
Creatinine concentration was measured by spectrophotom-
etry.
The fetal age of the neonates in the study ranged from 26
to42weeksofgestationandtheaveragebirthageofneonates
was 38 weeks of gestation. The majority (114) were term
births (77.55%). There were 33 (22.45%) preterm births.
There was no statistically signiﬁcant difference between the
g r o u p so fs u b j e c t si nt e r m so fs e x ,m e t h o do fd e l i v e r y ,o r
numbers of preterm births (Table 1). Measurement of the
head circumference was made immediately after birth with
the aid of a tape measure with an accuracy of up to 0.5 cm.
The head circumference was measured by passing the tape
measureovertheopisthocranionandmetopion.Thecerebral
mass was calculated according to the following equation:
cerebral mass (g) = 0.037 × head circumference (cm)2.57
(Lindley et al. 2000).
In order to determine the proportion of cerebral mass
to body mass, the brain body ratio (BBR) was calculated
according to the following equation: BBR = 100 × [0.037 ×
head circumference (cm)2.57]/body mass (g) (Lindley et al.
2000).
Table 1. Characteristics of the neonates.
Neonates with active Neonates with passive Neonates with
smoker mothers smoker mothers nonsmoker mothers
Characteristic n = 58 n = 64 n = 25 P-value
Sex
Male 32 (55.2%) 38 (59.4%) 15 (60.0%) n.s.
Female 26 (44.8%) 26 (40.6%) 10 (40.0%)
Gestational age
≥37 weeks 42 (72.4%) 52 (81.3%) 20 (80.0%) n.s.
<37 weeks 16 (27.6%) 12 (18.7%) 5 (20.0%)
Delivery
Spontaneous labor 32 (55.2%) 35 (54.7%) 12 (48.0%) n.s.
Vacuum extractor 1 (1.7%) 0 (0.0%) 1 (4.0%)
Cesarean section 25 (43.1%) 29 (45.3%) 12 (48.0%)
P-value compared with newborns of nonsmoking mothers.
n.s., not statistically signiﬁcant.
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The following tools were used for the statistical analysis:
(1) Descriptive statistics—average values, standard devia-
tions, medians, and ranges for quantitative variables.
(2) The Shapiro–Wilk test for testing the null hypothesis of
nodifferencebetweenthedistributionofthesubjectsandthe
normal distribution.
(3) The Kruskal–Wallis one-way analysis of variance for the
comparison of groups for quantitative variables with a non-
Gaussian distribution.
(4) Wilcoxon’s test for analysis of the differences between
two groups for quantitative variables with a non-Gaussian
distribution.
(5) Fisher’sexacttestforanalysisoftherelationshipbetween
quantitative variables.
The multi-dimensional logistic regression model (GLIM-
MIX) was used to calculate the odds ratio for the different
patientgr oupsasw ellasthem ultieq ui valentriskratiointhe
groups under comparison.
The relationship between maternal urinary cotinine con-
centration and the cerebral mass of the neonates was con-
ﬁrmedbyestimatingSpearman’srankcorrelationcoefﬁcient.
A P-value of <0.05 was taken as statistically signiﬁcant. Cal-
culations were made using the SAS system.
Results
The median measurement of head circumference for
neonates whose mothers were active smokers was 2 cm
smaller than for neonates whose mothers did not smoke and
this difference was statistically signiﬁcant at P = 0.002. The
medianheadcircumferencemeasurementofneonateswhose
mothers were passive smokers differed by 1 cm only, which
was not statistically signiﬁcant (Table 2).
Table 3. Odds ratio (OR) (95% conﬁdence interval [CI]) for brain weight
according to the smoker status of the mother, complications of preg-
nancy, sex, and gestational age of the neonate.
Brain weight OR
Independent variable (95% CI)
Active smoker versus nonsmoker 3.9 (1.4–10.8)
Passive smoker versus nonsmoker 1.9 (0.7–5.2)
Complications of pregnancy No/Yes 1.5 (0.8–3.0)
Newborn sex male/female 0.5 (0.3–0.9)
Gestational age <37 weeks/≥37 weeks 21.8 (8.2–57.8)
Neonates of mothers who were active smokers had signif-
icantly lower cerebral mass P = 0.002. The median cerebral
mass for children in this group was 295.65 g, and was 23.58 g
lowerthanthecerebralmassofneonateswhosemotherswere
passive smokers (319.23 g) and 48.27 g lower than the cere-
bral mass of neonates of non-smoker mothers (343.92 g).
The cerebral mass of neonates whose mothers were passive
smokers was 24.69 g lower than for neonates of nonsmoker
mothers; however, this difference was not statistically signif-
icant (Table 2).
There was a statistically signiﬁcant higher risk of lower
cerebral mass 3.9 (1.4–10.8, CI 95%) in neonates whose
mothers were active smokers when compared with those of
nonsmokermothers.Thisriskwasalsohigherintheneonates
whose mothers were passive smokers 1.9 (0.7–5.2, CI 95%);
however, this difference was not statistically signiﬁcant
(Table 3).
A negative correlation was evident between the maternal
urinary concentration of cotinine and the cerebral mass of
neonateswhosemotherswereactivesmokers.Thecorrelation
coefﬁcient (r) was negative and was –0.23 with P = 0.006,
Table 2. Median head circumference, brain weight, brain body ratio (BBR).
Variable Median Minimal value Maximal value Mean ± SD P-value
Head circumference (cm)
NN n = 25 35 32 38 34 ± 2
NP n = 64 34 27 37 34 ± 2n . s .
∗
NA n = 58 33 25 38 33 ± 2 0.002
∗
Brain weight (g)
NN n = 25 343.92 273.17 424.86 330.54 ± 42.40
NP n = 64 319.23 176.53 396.72 312.43 ± 52.42 n.s.
∗
NA n = 58 295.65 144.85 396.72 289.44 ± 53.41 0.002
∗
BBR
NN n = 25 9.56 7.68 12.11 9.70 ± 1.36
NP n = 64 9.26 6.61 16.16 9.80 ± 1.83 n.s.
∗
NA n = 58 9.56 7.51 15.60 10.22 ± 2.03 n.s.
∗
∗P-value against newborns of nonsmoking mothers.
n.s., not statistically signiﬁcant; NN, neonates with nonsmoker mothers; NP, neonates with passive smoker mothers; NA, newborns with active smoker
mothers.
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Figure 1. Correlation coefﬁcient (r) between cotinine concentration in
the mother’s urine and brain weight of the neonates.
which means that the neonatal cerebral mass fell with a rise
in maternal urinary cotinine concentration (Fig. 1).
There was no statistically signiﬁcant difference in the BBR
between the neonates whose mothers were active and those
whose mothers were passive smokers (9.56 and 9.26), and
thisratiowasidenticalinneonateswhosemotherswereactive
smokers and those whose mothers were nonsmokers (9.56)
(Table 2).
Discussion
Tobacco smoking throughout pregnancy affects the growth
of all anthropometric features (body mass, length, head, and
chestcircumference);however,theponderalindex,thatisthe
relative proportions of the body, remains unchanged, which
is evidence of symmetrical retardation of fetal interuterine
growth (Cliver et al. 1995; Roquer et al. 1995). It is difﬁcult
to assess the direct impact of tobacco smoke on the increase
incerebralmass.Manyauthorsusethemeasurementofhead
circumferencetoassessthedevelopmentofthebrain.Intheir
studies, Jaddoe et al. (2007) and Roza et al. (2007) measured
the weekly increase in the head circumference of fetuses of
smokercomparedwithnonsmokermothers.Growthretarda-
tion in terms of head circumference was −0.56 mm (−0.73,
−0.40, CI 95%) and −0.13 mm (−0.18, −0.09, CI 95%),
respectively (Jaddoe et al. 2007; Roza et al. 2007).
Many authors underline the signiﬁcant difference in the
head circumference of neonates whose mothers are active
smokers and nonsmokers and this difference ranges from
0.2 to 1.1 cm (Olds et al. 1994; Cliver et al. 1995; Roquer
et al. 1995; Zaren et al. 1996). In this study, the neonates
whose mothers were active smokers during pregnancy had
statistically smaller head circumference in comparison with
those whose mothers were nonsmokers. Based upon head
circumference, it is possible to estimate the cerebral mass of
theneonate[cerebralmass(g)=0.037×headcircumference
(cm)2.57] (Lindley et al. 2000).
In this study, the median cerebral mass of the neonates
whose mothers were active smokers during pregnancy was
statistically signiﬁcantly lower than the cerebral mass of
neonates of nonsmoker mothers. The cerebral mass of
neonateswhosemotherswerepassivesmokerswasalsolower
when compared with neonates born to nonsmoker mothers,
howeverthisdifferencewasnotstatisticallysigniﬁcant.What
is signiﬁcant is that the weight indicator BBR, which deter-
mines the proportion of cerebral to body mass, was identical
in the groups of neonates of active smoker and nonsmoker
mothers and was 9.56, which indicates the symmetrical re-
tardation of growth of the whole body. Mild reduction of
this indicator was observed in the group of neonates whose
mothers were passive smokers (9.26), but this difference was
not statistically signiﬁcant.
SimilarlyinthestudybyPichinietal.(2003),thisindicator
wasalmostidenticalinthegroupofneonateswhosemothers
were active, passive, or nonsmokers and these values were
10.5, 10.4, and 10.2, respectively.
According to Lindley, the average value of the BBR in
neonates whose mothers were nonsmokers was 9.45 and de-
creased by 0.074 [−0.031, −0.117, CI 95%] in the group of
neonateswhosemotherssmokedthroughoutthedurationof
pregnancy, if the mother smoked less than 10 cigarettes/day
andby0.046[−0.001,−0.091,CI95%]ifthemothersmoked
≥10 cigarettes/day, indicating that the head circumference
decreases in neonates whose mothers are smokers. Lindley
showedthatstoppingsmokinguptothe32weekofgestation
resultsinthesameBBRinneonateswhosemothersaresmok-
ers and those who have not smoked throughout the whole
pregnancy (Lindley et al. 2000).
The negative correlation between cerebral mass and ma-
ternal urinary cotinine concentration (a rise in cotinine con-
centration was accompanied by a decrease in cerebral mass)
demonstrated in this study is important evidence for the in-
ﬂuence of nicotine on the retardation of the development of
the brain. Impaired development of the fetal central nervous
system in smoker mothers is associated with a decrease in
the delivery of nutrients and oxygen to the fetus as well as
thedirect effectofnicotineanditsmetabolitesonbraincells.
Cigarette smoking by the mother has been shown to alter the
expression of nicotinic and muscarinicreceptors in the brain
stem and cerebellum of human fetuses, which impairs the
development of the cholinergic system (Falk et al. 2005).
Slotkin’s studies demonstrate that nicotine administered
in doses smaller than those that impair fetal growth, dam-
ages and reduces irreversibly the number of brain cells, and
damagestheactivityofneuralsynapses(Slotkin1998).Nico-
tine reaches the fetal brain from the maternal circulation
crossing through the blood/brain barrier without hindrance
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and damages the nicotine receptors in the human fetal brain
as early as the ﬁrst trimester of pregnancy (Cairns and
Wonnacott 1988).
Lower total cerebral mass was detected in neonatal rats
exposed to the effect of nicotine (dose 20–60 ng/mL). His-
tological changes were also registered in brain tissue in the
form of impaired maturation of pyramidal neurons, reduc-
tionofthepyramidalarea,andnarrowingofthecorticallayer
(Lambers and Clark 1996). The changes described above in
the brain ﬂows and the histological changes in the structure
of animal fetal brains subjected to the effects of nicotine can
be extrapolated to changes in humans. Albuquerque et al.
(2004), who studied the ﬂow in the middle cerebral artery
(MCA) in human fetuses, did not show any difference be-
tween the values of the resistance index in the MCA between
fetusesofsmokerandnonsmokermothers.Theydidhowever
ﬁnd a statistically signiﬁcant higher resistance index in the
MCAofmotherswhosmoked>10cigarettesper24h,which
isevidenceofincreasedresistanceofcerebralvasculatureand
of poorer cerebral blood supply (Albuquerque et al. 2004).
The investigations of Matturri et al. (2006) provide in-
teresting observations. They carried out histological exam-
ination the brains of neonates who had died from SIDS
and found hypoplastic changes in the nuclei (nucleus arcua-
tus) of the important centers for the circulatory–respiratory
system including the chemoreceptors as well as functional
changes in the brain stem centers. The morphological and
functional changes of the brainstem were associated with
maternal smoking in 91.36% of cases. The authors sug-
gest that fetal exposure to tobacco smoke, and therefore to
the effect of carboxyhemoglobin and chronic oxygen in-
sufﬁciency, impairs the formation of the nervous system
(Matturri et al. 2006). MRI examination undertaken in a
group of premature babies (<1500 g or <32 weeks of ges-
tation) who were exposed to the effect of nicotine in utero
showed statistically signiﬁcant reduction in the volume of
the frontal lobes and cerebellum, which in consequence
leads to impairment of their function and disturbance in
emotional control, behavior, and concentration in children
(Ekblad et al. 2010). A decrease of the thickness of the cere-
bral cortex in the fronto-orbital, midfrontal, and hippocam-
p u sr e g i o nw a ss h o w ni nc h i l d r e na n da d o l e s c e n t sw h ow e r e
exposedtotheeffectofnicotineinfetallife(Toroetal.2008).
Gale et al. (2004) showed that brain growth in the neonatal
period and early childhood has a greater effect on cognitive
function in children then during fetal life. In their study,
the IQ increased by 1.98 [0.34–3.62, CI 95%] for each ad-
ditional standard deviation in the increase in head circum-
ference at nine months of life and by 2.87 [1.05–4.69 CI
95%]foreachadditionalstandarddeviationinthenineyears
of life. They did not show any association with the IQ at
18 weeks of gestation or immediately after birth (Gale et al.
2004).
Conclusion
(1) Active smoking during pregnancy reduces the cerebral
mass of neonates; this effect was not evident in the case of
passive exposure to tobacco smoke.
(2) Thedeﬁciencyincerebralmassinneonateswhosemoth-
ers were smokers increased in conjunction with the intensity
of cigarette smoking.
(3) Active smoking of cigarettes by mothers during preg-
nancy retards both brain growth and increase in body mass
in neonates.
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